Copyright
©The Author(s) 2020.
World J Diabetes. Nov 15, 2020; 11(11): 553-566
Published online Nov 15, 2020. doi: 10.4239/wjd.v11.i11.553
Published online Nov 15, 2020. doi: 10.4239/wjd.v11.i11.553
Figure 1 Flow diagram showing the study selection process.
RCT: Randomized controlled trial; ET-1: Endothelin-1; ET-R: Endothelin-receptors.
- Citation: Zhang L, Xue S, Hou J, Chen G, Xu ZG. Endothelin receptor antagonists for the treatment of diabetic nephropathy: A meta-analysis and systematic review. World J Diabetes 2020; 11(11): 553-566
- URL: https://www.wjgnet.com/1948-9358/full/v11/i11/553.htm
- DOI: https://dx.doi.org/10.4239/wjd.v11.i11.553